
The Southeastern
United States
has a dynamic
and growing life sciences industry. There are currently 30 public
companies and more than 200
private biotech
companies in
the Southeast. Three Southeastern states – North
Carolina, Georgia and Florida – are among
the top ten U.S.
biotech centers, according to Ernst & Young’s Beyond Borders: The Global Biotechnology Report 2006.
North Carolina
is in third place
behind California and Massachusetts. Georgia improved
its ranking from
2004, climbing
from number 8 to number 7, while Florida
entered the top
ten list for the first time at number 10. To read a fact sheet
on the Southeast's biotech industry, click
here.
The growth of the
biotech industry
in the Southeast
remains strong, as further
evident from the 2006
Ernst & Young report, which shows:
- Total revenues for
the Southeast's
30 public companies in 2005 were $1.9 billion.
- Market capitalization
for these companies
was $8.9 billion.
- Public biotech companies
in the Southeast
invested $659 million
in R&D, a 20 percent
increase
over 2004.

There were approximately 204 deals in the
Southeast region in
2005, the third largest number of deals among
similar regions across
the United States, according
to The MoneyTree™ Report from
PricewaterhouseCoopers
and the National Venture
Capital Association based
on data from Thomson
Financial.
The Southeast has more life sciences communities than any other region. North
Carolina, with its Research Triangle Park centered between three world-class
universities, is home to 88 biotech companies and 100 biotech-related
companies, and is the leading center in the Southeast for biotechnology. Other
biotechnology centers have clustered around universities: in particular at the
University of Florida in Gainesville, where the primary focus is agriculture
and veterinary; the University of Alabama at Birmingham, where the focus is on
AIDS and cancer research; Georgia, at the private Emory University, where
primary research is on AIDS, cancer and infectious diseases in conjunction with
the Centers for Disease Control; Tennessee, at the private Vanderbilt
University, which looks at areas of human health, while the University of
Tennessee at Knoxville/Oak Ridge looks at environmental technologies; North Carolina, where Duke, a private institution, looks at most areas
of human health, while North Carolina State University focuses on agriculture
and the University of North Carolina at Chapel Hill looks at environment
biotechnologies; and finally, South Carolina is placing new emphasis on research with a significant increase in research dollars going to its three major research universities, Clemson University, the University of South Carolina, and the Medical University of South Carolina, while Charleston is home to a growing bioscience cluster strengthened by the presence of the Medical University. |
 |
 |
 |
 |
To learn more about the biotech activity in the seven
Southeastern states included in the SEBIO footprint, see below.
|
 |
 |
 |
 |
|